Found 7 matching trials
A Study of AK119 (Anti-CD73) in Combination With AK104 in Subjects With Advanced Solid Tumors
PHASE1This is a first-in-human (FIH), Phase 1a/1b, Multicenter, Open-Label, Dose-...
Location
Blacktown Cancer and Haematology Centre (Blacktown Hospital)
Study of AK119 in Subjects With Advanced Solid Tumors
PHASE1This is Phase 1, Multicenter, Open-Label, Dose-Escalation and Dose-Explorat...
Location
Fudan University Zhongshan Hospital
Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients
PHASE1This is a phase Ib/II study to evaluate the safety, tolerability, pharmacok...
Location
Guangdong Provincial People's Hospital
Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors
PHASE1This is a Phase Ib/II study to assess the safety, tolerability and prelimin...
Location
Peking Union Medical College Hospital
A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects
PHASE1This is a first-in-human (FIH), Phase 1, single-center, randomized, double-...
Location
Christchurch Clinical Studies Trust
A Phase Ib/II Clinical Study on AK112 Combined or Not Combined With AK119 in pMMR/MSS Colorectal Cancer
PHASE1This is an open label, multicenter Phase Ib/II clinical study on the effica...
Status
Active Not Recruiting
Location
Cancer Hospital Affiliated to Harbin Medical University
Study of AK119 Combined With AK104 in Patients With Advanced Solid Tumors
PHASE1This is a Phase Ib/II Study to evaluate the safety, tolerability, pharmacok...
Location
Tianjin Medical University Cancer Insitute & Hospital